View in EDS

PSY37 - Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab.

Saved in:

Bibliographic Details
Title:	PSY37 - Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab.
Authors:	Burge, RT¹, Papadimitropoulos, M², Henneges, C³, Garcia, EG⁴, Romiti, R⁵
Source:	Value in Health. Oct2017, Vol. 20 Issue 9, pA902-A902. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	10983015
DOI:	10.1016/j.jval.2017.08.2708